We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study: Earlier FDA-Industry Meeting Could Speed Drug Approvals
Study: Earlier FDA-Industry Meeting Could Speed Drug Approvals
February 17, 2006
Earlier meetings between the FDA and drugmakers could accelerate the drug approval process, says a new study commissioned by the agency.